Recognition, Diagnosis, and Management of Wilson's Disease
- 18 July 2008
- journal article
- Published by Wiley in Proceedings of the Society for Experimental Biology and Medicine
- Vol. 223 (1) , 39-46
- https://doi.org/10.1111/j.1525-1373.2000.22305.x
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- Isolation and Characterization of a Human Liver cDNA as a Candidate Gene for Wilson DiseaseBiochemical and Biophysical Research Communications, 1993
- Treatment of Wilson's disease with zinc: XI. Interaction with other anticopper agents.Journal of the American College of Nutrition, 1993
- Treatment of Wilson's disease with zinc. I. Oral zinc therapy regimensHepatology, 1987
- REVERSIBLE PANCYTOPENIA SECONDARY TO TREATMENT WITH TETRATH10‐MOLYBDATEBritish Journal of Haematology, 1986
- Copper metabolism in rats given di- or trithiomolybdatesJournal of Inorganic Biochemistry, 1982
- Copper and molybdenum absorption by rats given ammonium tetrathiomolybdateJournal of Inorganic Biochemistry, 1981
- Effects of molybdate, sulfide, and tetrathiomolybdate on copper metabolism in ratsJournal of Inorganic Biochemistry, 1981
- Oral Zinc Sulphate as Long-Term Treatment in Wilson’s Disease (Hepatolenticular Degeneration)European Neurology, 1979
- Neonatal Abnormalities Associated with D-Penicillamine Treatment during PregnancyNew England Journal of Medicine, 1977
- Defective biliary excretion of copper in Wilson's diseaseGut, 1974